Page last updated: 2024-08-24

carbenoxolone sodium and Esophageal Diseases

carbenoxolone sodium has been researched along with Esophageal Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davies, WA; Reed, PI2

Trials

2 trial(s) available for carbenoxolone sodium and Esophageal Diseases

ArticleYear
Controlled trial of a new dosage form of carbenoxolone (Pyrogastrone) in the treatment of reflux esophagitis.
    The American journal of digestive diseases, 1978, Volume: 23, Issue:2

    Topics: Adult; Aged; Alginates; Antacids; Carbenoxolone; Clinical Trials as Topic; Double-Blind Method; Esophageal Diseases; Esophagitis, Peptic; Esophagoscopy; Esophagus; Female; Humans; Male; Middle Aged; Triterpenes; Ulcer

1978
Controlled trial of a carbenoxolone/alginate antacid combination in reflux oesophagitis.
    Current medical research and opinion, 1978, Volume: 5, Issue:8

    Topics: Adult; Aged; Alginates; Carbenoxolone; Clinical Trials as Topic; Drug Combinations; Endoscopy; Esophageal Diseases; Esophagitis, Peptic; Female; Glycyrrhetinic Acid; Humans; Male; Middle Aged; Smoking; Ulcer

1978